Fresenius SE & Co. KGaA is a global healthcare group, which engages in the provision of products, and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate and Other. The Fresenius Medical Care segment is comprised of dialysis products, and healthcare services. The Fresenius Kabi segment provides intravenous drugs, clinical nutrition, infusion therapy, medical devices, and transfusion technology. The Fresenius Helios is the hospital operations. The Fresenius Vamed is consist of projects, and services for hospitals and other healthcare facilities. The Corporate and Other segment is the holding activities of the company and the information provider Fresenius Netcare. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.
With reporting season complete, where should you focus your attention? Using Skaffold we’ve come up with a collection of stocks that top the list for quality, performance, earnings per share growth and future growth in the underlying value of the business. In this webinar the team also share some tips to help you find the best stocks for your portfolio and provide expert insights into the companies that made the standouts report.
Companies listed on the ASX with a June year-end have been updated in Skaffold, now that the reporting season is complete. The big question is: where should investors focus their attention? Using four criteria we have come up with several standouts.